The meta-analysis of Roberts and colleagues (1) recently showed that statin treatment reduced all-cause mortality by 15% in older adults. Because the meta-analysis already included individuals from 60 years of age, and, on the other hand, recent concerns have been expressed about the benefits of lipid-lowering specifically in elderly people (2), we would like to present our prospective mortality data from a population with an average age of 80 years at baseline.
straightforward in old age, as is also reflected in studies published in this Journal during recent years (6, 7) . The relationship is complicated by the fact that an underlying pathologic condition may both lower cholesterol level and increase mortality risk. Therefore higher cholesterol may paradoxically reflect better prognosis in epidemiological studies. Our result is in accordance with the results from randomized trials of therapeutically lowered cholesterol (1) . It also concurs with earlier observational data of cardiovascular disease reduction in older patients treated with statins (8, 9) , and suggests that benefits may be even higher in real life than in clinical trials. We agree with Roberts and colleagues that older patients at cardiovascular risk should not have statin therapy withheld. 
